BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 28069048)

  • 1. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
    Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
    Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery.
    Nakagawa T; Toyazaki T; Chiba N; Ueda Y; Gotoh M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):560-6. PubMed ID: 27252238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of body mass index and outcomes following lobectomy for non-small-cell lung cancer.
    Wang C; Guo M; Zhang N; Wang G
    World J Surg Oncol; 2018 May; 16(1):90. PubMed ID: 29751759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
    Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
    Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
    Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
    Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
    Hyun SH; Lee KH; Choi JY; Kim BT; Kim J; Zo JI; Kim H; Kwon OJ; Ahn HK
    PLoS One; 2015; 10(12):e0145020. PubMed ID: 26684001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Low Body Mass Index With Poor Clinical Outcomes After Resection of Non-small Cell Lung Cancer.
    Takada K; Shimokawa M; Akamine T; Ono Y; Haro A; Osoegawa A; Tagawa T; Mori M
    Anticancer Res; 2019 Apr; 39(4):1987-1996. PubMed ID: 30952742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operative Risk for Major Lung Resection Increases at Extremes of Body Mass Index.
    Williams T; Gulack BC; Kim S; Fernandez FG; Ferguson MK
    Ann Thorac Surg; 2017 Jan; 103(1):296-302. PubMed ID: 27476820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study.
    Fukumoto K; Mori S; Shintani Y; Okami J; Ito H; Ohtsuka T; Toyooka S; Mori T; Watanabe SI; Asamura H; Chida M; Date H; Endo S; Nagayasu T; Nakanishi R; Miyaoka E; Okumura M; Yoshino I;
    Lung Cancer; 2020 Nov; 149():120-129. PubMed ID: 33010640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer.
    Sepesi B; Gold KA; Correa AM; Heymach JV; Vaporciyan AA; Roszik J; Dmitrovsky E; Liu X
    J Thorac Oncol; 2017 Aug; 12(8):1280-1287. PubMed ID: 28552766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative nutritional status assessment predicts postoperative outcomes in patients with surgically resected non-small cell lung cancer.
    Ramos R; Nadal E; Peiró I; Masuet-Aumatell C; Macia I; Rivas F; Rosado G; Rodriguez P; Ureña A; Padrones S; Aso S; Deniz C; Navarro A; Escobar I
    Eur J Surg Oncol; 2018 Sep; 44(9):1419-1424. PubMed ID: 29685760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC).
    Lam VK; Bentzen SM; Mohindra P; Nichols EM; Bhooshan N; Vyfhuis M; Scilla KA; Feigenberg SJ; Edelman MJ; Feliciano JL
    Lung Cancer; 2017 Feb; 104():52-57. PubMed ID: 28213000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Body Mass Index Is an Independent Predictive Factor after Surgical Resection in Patients with Non-Small Cell Lung Cancer.
    Tomita M; Ayabe T; Nakamura K
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3353-3356. PubMed ID: 29286350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of postoperative non-steroidal anti-inflammatory drugs on long-term survival and recurrence of patients with non-small cell lung cancer.
    Jiang W; Wang L; Zhang J; Shen H; Dong W; Zhang T; Li X; Wang K; Du J
    Medicine (Baltimore); 2018 Sep; 97(39):e12442. PubMed ID: 30278522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in the correlation between prognosis and postoperative weight loss in patients with non-small cell lung cancer.
    Kawai H; Saito Y; Suzuki Y
    Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):272-277. PubMed ID: 28444319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.